Abstract: The present subject matter relates to methods for the synthesis of [6,6]-phenyl-C61-butyric acid methyl ester (PCBM) and fullerene derivatives in a yield of at least 40%.

Abstract: Aligned multi-walled carbon nanotubes were grown on both sides of a metallic or metal-coated substrate by water vapor-assisted chemical vapor deposition. Aligned carbon nanotube films of thickness ranging from 1 ?m to over 100 ?m were obtained. By manipulating various operating factors—position of substrate in the reactor, amount of water vapor, amount of catalyst, reactor temperature, and growth time, the morphology and thickness of these carbon nanotube films could be adjusted.

Abstract: The present disclosure includes a method for preparing an aqueous dispersion of ?-Fe2O3 nanoparticles. The method includes grinding an iron (II) hydrated salt, an iron (III) hydrated salt, an inorganic salt, and alkali hydroxide in a grinding or milling machine. The inorganic salt may be a salt matrix that prevents growth and aggregation of the synthesized nanoparticles. The aqueous dispersion of ?-Fe2O3 nanoparticles may optionally be hydrothermally treated to become an aqueous dispersion of ?-Fe2O3 nanoparticles. Also disclosed is a method for preparing an mixture of ?-Fe2O3 nanoparticles and ?-Fe2O3 nanoparticles, in which at least an iron (III) hydrated salt, an inorganic salt, and alkali hydroxide are ground in a grinding or milling machine. Uses for the nanoparticles include: a magnetic resonance image contrast agent, a color print ink, an artificial tanning pigment, a photocatalyst for degradation of organic dye, a red pigment, an adsorbent for waste water treatment, a catalyst support, and a catalyst.

Abstract: The present invention is a method for simultaneously separating two highly pure fullerenes from a mixture of fullerenes via crystallization, by (i) adjusting the amount of solvent in the mixture fed to a first crystallizer to obtain a phase equilibrium behavior so a first fullerene component of the two fullerenes, in the form of pure crystal, solid solution crystal, or solvate crystal is obtained; (ii) adjusting the amount of solvent in another mixture fed to a second crystallizer, operating at a temperature different from the first crystallizer, to obtain a phase equilibrium behavior so a second fullerene component of the two fullerenes, in the form of pure crystal, solid solution crystal, or solvate crystal is obtained; and additionally (iii) purifying the solid solution or the solvate into highly pure fullerene, when the solid product from the crystallizers is in the form of solid solution or solvate.

Abstract: The present subject matter provides a time- and energy-saving paste-state mechanochemical process to synthesize zinc oxide nanoparticles. Our nanoparticles are small, have abundant surface hydroxyl groups and exhibit excellent UV blocking characteristics. One embodiment involves a process for preparing zinc oxide nanoparticles comprising grinding, milling, or a combination thereof a mixture comprising (a) at least one zinc salt, (b) at least one additional inorganic salt, and (c) at least one alkali hydroxide compound.

Abstract: This invention relates to a novel soy isoflavone product with high purities and strong biological activities and the method of producing the same from natural soybeans, soybean materials (i.e. tofu dregs, soy molasses) and other plant sources. The method includes three steps consisting of extraction with an organic solvent, hydrolysis using an acid and crystallization using an antisolvent. The procedure is very simple and thus can be easily adapted for large-scale manufacturing. Moreover, the procedure is able to produce a high yield of total isoflavones at a lower cost. HPLC analysis and E-Screen bioassay reveal that the obtained product not only contains a high content of isoflavone aglycones by weight of dry matter but also exhibits strong estrogenic activity toward human cells. Therefore, the product should be efficacious for relieving menopausal symptoms and other estrogen-deficient diseases and can be used in health care supplements or as additives for foods, beverages or cosmetics.

Abstract: The present disclosure includes a method for preparing an aqueous dispersion of ?-Fe2O3 nanoparticles. The method includes grinding an iron (II) hydrated salt, an iron (III) hydrated salt, an inorganic salt, and alkali hydroxide in a grinding or milling machine. The inorganic salt may be a salt matrix that prevents growth and aggregation of the synthesized nanoparticles. The aqueous dispersion of ?-Fe2O3 nanoparticles may optionally be hydrothermally treated to become an aqueous dispersion of ?-Fe2O3 nanoparticles. Also disclosed is a method for preparing an mixture of ?-Fe2O3 nanoparticles and ?-Fe2O3 nanoparticles, in which at least an iron (III) hydrated salt, an inorganic salt, and alkali hydroxide are ground in a grinding or milling machine. Uses for the nanoparticles include: a magnetic resonance image contrast agent, a color print ink, an artificial tanning pigment, a photocatalyst for degradation of organic dye, a red pigment, an adsorbent for waste water treatment, a catalyst support, and a catalyst.

Abstract: Aligned multi-walled carbon nanotubes were grown on both sides of a metallic or metal-coated substrate by water vapor-assisted chemical vapor deposition. Aligned carbon nanotube films of thickness ranging from 1 ?m to over 100 ?m were obtained. By manipulating various operating factors—position of substrate in the reactor, amount of water vapor, amount of catalyst, reactor temperature, and growth time, the morphology and thickness of these carbon nanotube films could be adjusted.

Abstract: This invention relates to a novel soy isoflavone product with high purities and strong biological activities and the method of producing the same from natural soybeans, soybean materials (i.e. tofu dregs, soy molasses) and other plant sources. The method includes three steps consisting of extraction with an organic solvent, hydrolysis using an acid and crystallization using an antisolvent. The procedure is very simple and thus can be easily adapted for large-scale manufacturing. Moreover, the procedure is able to produce a high yield of total isoflavones at a lower cost. HPLC analysis and E-Screen bioassay reveal that the obtained product not only contains a high content of isoflavone aglycones by weight of dry matter but also exhibits strong estrogenic activity toward human cells. Therefore, the product should be efficacious for relieving menopausal symptoms and other estrogen-deficient diseases and can be used in health care supplements or as additives for foods, beverages or cosmetics.